APP insider filing: 17,500 common shares planned sale via Morgan Stanley

Rhea-AI Filing Summary

Applovin Corporation (APP) Form 144 notifies a proposed sale of 17,500 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $7,328,300.00. The shares are scheduled for sale on 08/22/2025 on NASDAQ. The shares were acquired on 02/01/2012 as founders' shares from the issuer and were fully paid on that date.

The filing also discloses recent 10b5-1 sales executed on 05/23/2025 by related accounts, including sales of 17,500, 30,000, 17,500, and 17,500 shares generating gross proceeds reported in the filing. The filer certifies they are not aware of undisclosed material adverse information at the time of the notice.

Positive

• Brokered sale through Morgan Stanley Smith Barney LLC indicates use of an established execution channel
• Prior 10b5-1 sales disclosed, showing disposition activity under compliance plans
• Acquisition date disclosed (02/01/2012), clarifying holding period and origin as founders' shares

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice showing a modest sale via broker and recent 10b5-1 activity; not a material capital event.

The filing reports a proposed sale of 17,500 common shares valued at $7.33 million to be executed on NASDAQ through Morgan Stanley Smith Barney LLC. The shares were acquired as founders' shares in 2012. Multiple 10b5-1 sales on 05/23/2025 are disclosed, indicating prior planned disposition activity by related accounts. Given the company's reported outstanding share count of 307,636,373, the proposed sale represents a very small fraction of outstanding equity, so it is unlikely to have a material market impact on its own.

Compliance / Corporate Governance Expert

TL;DR: Filing follows Rule 144 disclosure conventions and cites 10b5-1 sales; procedural compliance appears documented.

The notice includes required acquisition details (date, nature as founders' shares) and broker information for the planned sale. It also lists recent 10b5-1 plan sales and contains the standard representation that the seller is unaware of undisclosed material adverse information. From a governance standpoint, the filing contains the elements needed for Rule 144 transparency: class, amount, acquisition history, broker, and past 10b5-1 sales. The document does not provide additional corporate developments or material nonpublic facts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17500	7328300.00	307636373	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2012	Founders Shares	Issuer			17500	02/01/2012	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ES 48 HOLDINGS TRUST U/A DTD 09/07/2023 1100 Page Mill Road Palo Alto CA 94304	Common	05/23/2025	17500	6187370.00
10b5-1 Sales for BASIL SHIKIN 1100 Page Mill Road Palo Alto CA 94304	Common	05/23/2025	30000	10606920.00
10b5-1 Sales for IS37 HOLDINGS TRUST U/A DTD09/07/2023 1100 Page Mill Road Palo Alto CA 94304	Common	05/23/2025	17500	6187370.00
10b5-1 Sales for IK50 HOLDINGS TRUST U/A DTD09/07/2023 1100 Page Mill Road Palo Alto CA 94304	Common	05/23/2025	17500	6187370.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold in the Applovin (APP) Form 144?

The filing proposes sale of 17,500 common shares of Applovin to be executed on 08/22/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the proposed APP sale?

The aggregate market value reported for the proposed sale is $7,328,300.00.

When and how were the shares being sold acquired?

The shares were acquired on 02/01/2012 as founders' shares from the issuer and were fully paid on that date.

Did the filer recently sell other APP shares?

Yes. The filing lists several 10b5-1 sales on 05/23/2025, including sales of 17,500, 30,000, 17,500, and 17,500 common shares with gross proceeds shown for each sale.

Does the filer assert possession of material nonpublic information?

The filer represents by signing the notice that they do not know any material adverse information